These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Transmission blocking vaccine studies in leishmaniasis: I. Lipophosphoglycan is a promising transmission blocking vaccine molecule against cutaneous leishmaniasis. Tonui WK, Mbati PA, Anjili CO, Orago AS, Turco SJ, Githure JI, Koech DK. East Afr Med J; 2001 Feb; 78(2):84-9. PubMed ID: 11682952 [Abstract] [Full Text] [Related]
4. Transmission blocking vaccine studies in leishmaniasis: II. Effect of immunisation using Leishmania major derived 63 kilodalton glycoprotein, lipophosphoglycan and whole parasite antigens on the course of L. major infection in BALB/c mice. Tonui WK, Mbati PA, Anjili CO, Orago AS, Turco SJ, Githure JI, Koech DK. East Afr Med J; 2001 Feb; 78(2):90-2. PubMed ID: 11682953 [Abstract] [Full Text] [Related]
5. Estimation of the minimum number of Leishmania major amastigotes required for infecting Phlebotomus duboscqi (Diptera: Psychodidae). Anjili C, Langat B, Lugalia R, Mwanyumba P, Ngumbi P, Mbati PA, Githure J, Tonui WK. East Afr Med J; 2006 Feb; 83(2):68-71. PubMed ID: 16708876 [Abstract] [Full Text] [Related]
7. The effect of avian blood on Leishmania development in Phlebotomus duboscqi. Pruzinova K, Votypka J, Volf P. Parasit Vectors; 2013 Sep 02; 6(1):254. PubMed ID: 24059328 [Abstract] [Full Text] [Related]
8. Laboratory demonstration of the acquisition and development of leishmania major in the sand fly Phlebotomus kazeruni (Diptera: Psychodidae). Hanafi HA, Fryauff DJ, Dykstra EA, Szumlas DE. J Egypt Soc Parasitol; 2007 Apr 02; 37(1):227-41. PubMed ID: 17580580 [Abstract] [Full Text] [Related]
19. Epitope mapping of monoclonal antibodies directed against lipophosphoglycan of Leishmania major promastigotes. Kelleher M, Curtis JM, Sacks DL, Handman E, Bacic A. Mol Biochem Parasitol; 1994 Aug 12; 66(2):187-200. PubMed ID: 7808469 [Abstract] [Full Text] [Related]